Plante Moran Financial Advisors, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1424717 SOUTHFIELD, MI

Position in REGN

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$623

-$2,011 QoQ

Shares Held

-66.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1,314

of 1,322 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Plante Moran Financial Advisors, LLC holds $543,889 across 38 Biotechnology names. REGN ranks #20 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RLAY	Relay Therapeutics, Inc.	10,836	$202,741
2	ALNY	Alnylam Pharmaceuticals, Inc.	636	$191,455
3	VRTX	Vertex Pharmaceuticals Inc / Ma	171	$84,940
4	SABS	SAB Biotherapeutics, Inc.	5,925	$23,107
5	OMER	Omeros Corp	1,000	$9,510
6	ARGX	Argenx SE	7	$6,494
7	BHVN	Biohaven Ltd.	362	$5,386
8	KRYS	Krystal Biotech, Inc.	6	$2,230

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$623	1	-66.7%	Shares	Sole	2026-08-06
2023-12-31	$2,634	3	-40.0%	Shares	Sole	2024-02-05
2022-09-30	$3,444	5	0.0%	Shares	Sole	2022-11-02
2022-06-30	$2,955	5	0.0%	Shares	Sole	2022-08-02
2022-03-31	$3,492	5	-50.0%	Shares	Sole	2022-05-06
2021-12-31	$6,315	10	-92.2%	Shares	Sole	2022-02-09
2021-09-30	$78,068	129	+4.9%	Shares	Sole	2021-11-08
2021-06-30	$68,700	123	+17.1%	Shares	Sole	2021-08-10
2021-03-31	$49,679	105	-1.9%	Shares	Sole	2021-05-13
2020-12-31	$51,692	107	-46.5%	Shares	Sole	2021-02-09
2020-03-31	$97,658	200	—	Shares	Sole	2020-05-07
No filing history on record for this holder in this stock.